UC neurosurgeon awarded grant for tumor research
Matthew Garrett, MD, PhD, who specializes in neuro-oncology, recently received a $50,000 grant from the Neurosurgery Research and Education Foundation.
The 2021-2022 B*CURED and NREF Young Clinician Investigator Award is only given to junior faculty who are pursuing careers as clinical investigators. Only those neurosurgeons who have completed fellowship within the last two years are eligible to apply.
The award-winning project, titled, “Targeting the malignant epigenome of IDH1 mutant gliomas,” intends to investigate a treatment for Diffuse Intrinsic Pontine Glioma (DIPG). DIPG is a rare brainstem tumor that occurs primarily in children. There is currently no cure, and it is universally fatal.
"The most commonly accepted hypothesis is that the tumors are initiated when a mutation affects the way the tumor DNA is folded and arranged,” said Garrett, assistant professor of clinical neurosurgery in the University of Cincinnati College of Medicine and a UC Health Neurosurgeon at the UC Gardner Neuroscience Institute.
Garrett’s study proposes using chaetoin, an untested compound discovered from a drug screen of hundreds of different compounds, to make tumor cells more sensitive to radiation.
Garrett will test the efficacy of this compound by injecting the human tumor cells into mice. His study will both treat the mice with this new compound and will also treat the mice with the compound in combination with other promising therapies like radiation and Panobinostat.
Featured photo at top of UC Gardner Neuroscience Institute by Mark Herboth.
Related Stories
Can new rules in Ohio address a pharmacy staffing shortage and...
May 17, 2024
The University of Cincinnati's Michael Hegener joined WVXU's Cincinnati Edition to discuss recent rules released by the Ohio Board of Pharmacy designed to address pharmacy staffing.
Is ketamine the answer to treatment-resistant depression?
May 16, 2024
The University of Cincinnati's Stephen Rush joined WVXU's Cincinnati Edition to discuss the use of ketamine and esketamine to treat treatment-resistant depression.
UC study: Severe ischemic strokes rare in total patient...
May 15, 2024
The University of Cincinnati’s Yasmin Aziz will present research at the European Stroke Organisation Conference that found severe ischemic strokes with the most severe damage are rare in the total stroke patient population.